After the announcement of its new anti-obesity treatment, Novo Nordisk jumps on the stock market and overtakes Tesla. Thursday evening, the Scandinavian pharmaceutical laboratory was worth some 556 billion euros, or 40 billion more than Tesla.
The manufacturer of the popular weight loss products Wegovy and Ozempic climbs two rungs in the ranking of the most valuable companies in the world and settles in twelfth place. According to several analysts, its value is expected to reach $100 billion in 2030.